ICCC.US ImmuCell Corporation

Healthcare Biotechnology USA Stocks
10.75 USD
Close of Nov 15, 2026
4.52 12.10
Market cap
USD 97.7M
P/E
56.6x
P/B
2.98x
ROE
19.2%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is ICCC.US undervalued?

Graham number
Price10.75
Graham value3.93
Premium173.8%

ICCC.US trades 173.8% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

ImmuCell Corporation fundamental analysis

No fundamental analysis for ImmuCell Corporation yet.

ImmuCell Corporation stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About ImmuCell Corporation

ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that improves the health and productivity of dairy and beef cattle in the United States and internationally. It operates through two segments, Scours and Mastitis. The company offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment o…

Full company profile